ARCHIVES

ODAC Member Critical Of Amgen For Price Incentives.

This article is from The Cancer Letter archive.

Vol. 34 No. 11 | March 21, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: Van Andel Institute to Build Epigenetics Hub

February 28, 2014

Agricultural Pesticide Use Linked To Prostate Cancer

July 25, 2003

In Brief: Terry To Leave NCI for Job As VP Of Revlon Health Care Group; NCI Tracking Source Of Breakthroughs

June 18, 1982

NCI Seeks $5.799 Billion In FY08 Bypass Budget

November 17, 2006

In Brief: Pretreatment Critical In Antimetic Therapy, Sallan Says; Aging/Cancer Symposium Planned

July 11, 1980

In Brief: Upton Says Delaney Clause Is Needed: CPSC Drops Effort To Set Policy On Carcinogens

May 4, 1979